Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space - 2Vote In favor of Your Favored Pizza Cover
- 3Pfizer in $41.5 million settlement with Texas over ADHD drug for children
- 47 Powerful Methods for forestalling Telephone Overheating: Keep Your Gadget Cool
- 5Astronauts' brains change shape and position after time in space, study finds
- Munich Security Conference chief defends inviting AfD lawmakers
- Instructions to Clean and Really focus on Your Lab Precious stone
- What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- Hezbollah claims right to respond to killing of top commander
- Philippines evacuates 3,000 villagers after volcano activity raises alert level
- 2023's Best 10 Cell phone Advancements You Can't Miss
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- Change Your Physical make-up: Compelling Activities for Muscle Building
- FDA approves Wegovy pill for weight loss: What to know
